Conference Speakers

Conference Speakers and Panelists | 2024
*As of September 21st, 2023

Mira Chaurushiya

Managing Director, Westlake Village BioPartners

John Connolly

Chief Scientific Officer, Parker Institute for Cancer Immunology

Richard DiMarchi

Professor, Indiana University

Dalton Einhorn

Global Head of Pharmaceutical Corporate Venture Capital, Asahi Kasei Pharma

Jason Hafler

Managing Director, Sanofi Ventures

Richard Heyman, Ph.D.

Executive Chairman, Metacrine

Tony Ho

Chief Scientific Officer & Senior Science Partner, Pivotal Lifesciences

Kim Kamdar

Partner, Medical Excellence Capital

Rachna Khosla

Senior Vice President, Business Development, Amgen

Stuart Mackey

Global Head of Business Development, Daiichi Sankyo

Mathai Mammen

CEO, President and Chairman, FogPharma

Konstantina Manjoros Katcheves

Senior Vice President Business Development, Bristol Myers Squibb

Peter Meinke

Sanders Director, Tri-Institutional Therapeutics Discovery Institute, Inc

Detlev Mennerich

Corporate SVP, Global Head of Business Development & Licensing, Boehringer Ingelheim

Carole Nuechterlein

Head, Roche Venture Fund

Sunil Patel

Senior Vice President & Head of Corporate Development, Merck

Emma Parmee

Global Head Therapeutics Discovery at The Janssen Pharmaceutical Companies of Johnson & Johnson

Jeremy Quirk

VP BD&L Commercial Portfolio, GSK

Camille Samuels

Partner, Venrock

Uwe Schoenbeck

Senior Vice President and CSO, Emerging Science and Innovation (ES&I), Pfizer Worldwide Research Development and Medical, Pfizer

Peter Schultz

Scripps Family Chair Professor, President and CEO, Department of Chemistry, The Scripps Research Institute

Andy Schwab

Founder and Managing Partner, 5AM Ventures

Ben Ben Sklaroff

CTO, Co-Founder, Genesis Therapeutics

Tari Suprapto

Director, Search & Evalutation (West), Novo Nordisk